Literature DB >> 23427153

Genetic screen of a mutant poxvirus library identifies an ankyrin repeat protein involved in blocking induction of avian type I interferon.

Stephen M Laidlaw1, Rebecca Robey, Marc Davies, Efstathios S Giotis, Craig Ross, Karen Buttigieg, Stephen Goodbourn, Michael A Skinner.   

Abstract

Mammalian poxviruses, including vaccinia virus (VACV), have evolved multiple mechanisms to evade the host type I interferon (IFN) responses at different levels, with viral proteins targeting IFN induction, signaling, and antiviral effector functions. Avian poxviruses (avipoxviruses), which have been developed as recombinant vaccine vectors for permissive (i.e., poultry) and nonpermissive (i.e., mammals, including humans) species, encode no obvious equivalents of any of these proteins. We show that fowlpox virus (FWPV) fails to induce chicken beta IFN (ChIFN2) and is able to block its induction by transfected poly(I·C), an analog of cytoplasmic double-stranded RNA (dsRNA). A broad-scale loss-of-function genetic screen was used to find FWPV-encoded modulators of poly(I·C)-mediated ChIFN2 induction. It identified fpv012, a member of a family of poxvirus genes highly expanded in the avipoxviruses (31 in FWPV; 51 in canarypox virus [CNPV], representing 15% of the total gene complement), encoding proteins containing N-terminal ankyrin repeats (ANKs) and C-terminal F-box-like motifs. Under ectopic expression, the first ANK of fpv012 is dispensable for inhibitory activity and the CNPV ortholog is also able to inhibit induction of ChIFN2. FWPV defective in fpv012 replicates well in culture and barely induces ChIFN2 during infection, suggesting that other factors are involved in blocking IFN induction and resisting the antiviral effectors. Nevertheless, unlike parental and revertant viruses, the mutants induce moderate levels of expression of interferon-stimulated genes (ISGs), suggesting either that there is sufficient ChIFN2 expression to partially induce the ISGs or the involvement of alternative, IFN-independent pathways that are also normally blocked by fpv012.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23427153      PMCID: PMC3624286          DOI: 10.1128/JVI.02736-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Transient dominant selection of recombinant vaccinia viruses.

Authors:  F G Falkner; B Moss
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

2.  Coding sequences of both genome segments of a European 'very virulent' infectious bursal disease virus.

Authors:  M D Brown; M A Skinner
Journal:  Virus Res       Date:  1996-01       Impact factor: 3.303

3.  Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase.

Authors:  J C Watson; H W Chang; B L Jacobs
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

4.  Temperature-sensitive mutants in the vaccinia virus A18R gene increase double-stranded RNA synthesis as a result of aberrant viral transcription.

Authors:  C D Bayliss; R C Condit
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

5.  Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity.

Authors:  J A Symons; A Alcamí; G L Smith
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

6.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.

Authors:  H W Chang; J C Watson; B L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

7.  Cyclic AMP response element-binding protein and the catalytic subunit of protein kinase A are present in F9 embryonal carcinoma cells but are unable to activate the somatostatin promoter.

Authors:  N Masson; M Ellis; S Goodbourn; K A Lee
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling.

Authors:  O R Colamonici; P Domanski; S M Sweitzer; A Larner; R M Buller
Journal:  J Biol Chem       Date:  1995-07-07       Impact factor: 5.157

9.  A family of genes coding for two serologically distinct chicken interferons.

Authors:  C Sick; U Schultz; P Staeheli
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

10.  Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation.

Authors:  R Marais; Y Light; H F Paterson; C J Marshall
Journal:  EMBO J       Date:  1995-07-03       Impact factor: 11.598

View more
  11 in total

1.  Genetic screen of a library of chimeric poxviruses identifies an ankyrin repeat protein involved in resistance to the avian type I interferon response.

Authors:  Karen Buttigieg; Stephen M Laidlaw; Craig Ross; Marc Davies; Stephen Goodbourn; Michael A Skinner
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

Review 2.  Poxviral ankyrin proteins.

Authors:  Michael H Herbert; Christopher J Squire; Andrew A Mercer
Journal:  Viruses       Date:  2015-02-16       Impact factor: 5.048

3.  Chicken interferome: avian interferon-stimulated genes identified by microarray and RNA-seq of primary chick embryo fibroblasts treated with a chicken type I interferon (IFN-α).

Authors:  Efstathios S Giotis; Rebecca C Robey; Natalie G Skinner; Christopher D Tomlinson; Stephen Goodbourn; Michael A Skinner
Journal:  Vet Res       Date:  2016-08-05       Impact factor: 3.683

4.  Recombinant fowlpox virus vector-based vaccines: expression kinetics, dissemination and safety profile following intranasal delivery.

Authors:  David G Townsend; Shubhanshi Trivedi; Ronald J Jackson; Charani Ranasinghe
Journal:  J Gen Virol       Date:  2017-04-01       Impact factor: 3.891

5.  Constitutively elevated levels of SOCS1 suppress innate responses in DF-1 immortalised chicken fibroblast cells.

Authors:  E S Giotis; C S Ross; R C Robey; A Nohturfft; S Goodbourn; M A Skinner
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

6.  Orientia tsutsugamushi uses two Ank effectors to modulate NF-κB p65 nuclear transport and inhibit NF-κB transcriptional activation.

Authors:  Sean M Evans; Kyle G Rodino; Haley E Adcox; Jason A Carlyon
Journal:  PLoS Pathog       Date:  2018-05-07       Impact factor: 6.823

7.  Chicken Embryonic-Stem Cells Are Permissive to Poxvirus Recombinant Vaccine Vectors.

Authors:  Efstathios S Giotis; Guillaume Montillet; Bertrand Pain; Michael A Skinner
Journal:  Genes (Basel)       Date:  2019-03-20       Impact factor: 4.141

8.  Chicken cGAS Senses Fowlpox Virus Infection and Regulates Macrophage Effector Functions.

Authors:  Marisa Oliveira; Damaris Ribeiro Rodrigues; Vanaique Guillory; Emmanuel Kut; Efstathios S Giotis; Michael A Skinner; Rodrigo Guabiraba; Clare E Bryant; Brian J Ferguson
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

9.  Construction of Deletion-knockout Mutant Fowlpox Virus (FWPV).

Authors:  Stephen M Laidlaw; Michael A Skinner
Journal:  Bio Protoc       Date:  2014-05-20

10.  Characterization of Chicken Tumor Necrosis Factor-α, a Long Missed Cytokine in Birds.

Authors:  Franziska Rohde; Benjamin Schusser; Tomáš Hron; Helena Farkašová; Jiří Plachý; Sonja Härtle; Jiří Hejnar; Daniel Elleder; Bernd Kaspers
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.